Knowledge graph · Cancer
Mastocytosis
hematologic malignancy
- Identifier
- CI-CAN-00001194
- Entity page
- /cancer/mastocytosis ↗
- Edges
- 134
- Neighbours
- 17 drugs10 trials
- Drawn
- 27 of 27 neighbours (cap 60); table lists every fetched edge
Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.
Most connectedLung Non-Small Cell Carcinoma 3,147Malignant Colorectal Neoplasm 1,866ABL1 298EGFR 276Imatinib 450Dasatinib 321
Neighbourhood
Radial view
Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.
Edges
Every edge, grouped by relationship
Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.
| Relationship | Neighbour | Direction | Evidence level | Cancer context | Support | Claim | Source | Expand |
|---|---|---|---|---|---|---|---|---|
| Mastocytosis approved for …APPROVED_FOR4 of 3 | ||||||||
| ← approved for | Midostaurinsmall_molecule | supports | mesh_therapeutic_area | Mastocytosis | 1 | Regulatory | ema | graph → |
| ← approved for | Imatinibsmall molecule FDA (US) · approved · 2024-11-22 · Adult patients with aggressive systemic mastocytosis (ASM) without the D816V c-Kit mutation or with c-Kit mutational status unknown. | |||||||